Anti-double-stranded DNA antibodies in the healthy elderly: Prevalence and characteristics
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Using Crithidia luciliae fluorescent assay a significant prevalence (7.6%; P less than 0.006) of anti-double-stranded DNA antibodies was found in a healthy old population. A negative enzyme-linked immunosorbent assay for anti-total histone antibodies excluded a false-positive reaction. Anti-double-stranded DNA antibodies in the aged differed from those found in patients with systemic lupus erythematosus and were characterized by a low titer (95.6% of cases), belonging to the IgA class alone (95.6%), no complement-fixing ability (100%), and negativity to Farr assay (100%). It is concluded that, in elderly subjects without signs and symptoms of disease, including systemic lupus erythematosus, such a peculiar anti-double-stranded DNA antibody may be detected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple forms of cytoDNA may be secreted and act as a cell non-autonomous signal in physiology and disease, which has been proposed as a biomarker for sterile inflammation (Ruffatti et al., 1990).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Ruffatti et al., 1990
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · cited 1×
“For comparison, the sera of 38 patients (4 men and 34 women, aged between 13 and 58 years; mean age, 36.6 years) affected with SLE were also screened. They fulfilled the ARA criteria ( 21 ).”
InfluentialAdmission criteria for immunogerontological studies in man: The senieur protocol
Ligthart, G. J., Corberand, J. X., Fournier, C., Galanaud, P., Hijmans, W., Kennes, B., Müller-Hermelink, H. K., & Steinmann, G. G. (1984) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(84)90152-0 · Cited by 754 · cited 1×
“All lived in old people's homes and were selected according to the SENIEUR protocol for immunogerontological studies in man (19).”
High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.
Manoussakis, M. N., Tzioufas, A. G., Silis, M. P., Pange, P. J. E., Goudevenos, J. A., & Moutsopoulos, H. Μ. (1987) · PubMed · Cited by 339
Lymphocyte Phytohemagglutinin Responsiveness, Immunoglobulins and Autoantibodies in Aging Humans
Hallgren, H. M., Buckley, C. E., Gilbertsen, V. A., & Yunis, E. J. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.111.4.1101 · Cited by 282 · cited 1×
“It is also interesting to stress that the striking prevalence of IgA isotype may be in keeping with increased levels of IgA immunoglobulins described in the healthy aged (15, 25, 26).”
Tan, E. M., Chan, E. K. L., Sullivan, K. F., & Rubin, R. L. (1988) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(88)90066-9 · Cited by 271 · cited 1×
“They are highly specific for SLE, rarely being found in patients with other disorders, especially at high titers (1).”
The first international standard for antibodies to double stranded DNA
Feltkamp, T. E., Kirkwood, T. B., Maini, R. N., & Aarden, L. A. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.9.740 · Cited by 97
Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.
Smeenk, R., van der Lelij, G., & Aarden, L. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.1.73 · Cited by 90 · cited 1×
“Moreover, it may be assumed that the Crithidia-positive sera of the elderly, being negative to Farr assay, are the low-avidity antidsDNA antibodies; in fact, the Fan" assay is considered a suitable method for detection only of high-avidity antibodies (10).”
Aarden, L. A., Lakmaker, F., & Feltkamp, T. E. W. (1976) · Journal of Immunological Methods · doi:10.1016/0022-1759(76)90004-1 · Cited by 73
CHUBICK, A., SONTHEIMER, R. D., GILLIAM, J. N., & ZIFF, M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-2-186 · Cited by 55
Autoantibodies to intracellular proteins
Christian, C. L., & Elkon, K. B. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90048-3 · Cited by 53
Cited by
The use of laboratory tests in the diagnosis of SLE
Egner, W. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.6.424 · Cited by 316
Cytoplasmic DNA: sources, sensing, and role in aging and disease
Miller, K. N., Victorelli, S. G., Salmonowicz, H., Dasgupta, N., Liu, T., Passos, J. F., & Adams, P. D. (2021) · Cell · doi:10.1016/j.cell.2021.09.034 · Cited by 288
Serum antibodies in epilepsy and seizure-associated disorders
McKnight, K., Jiang, Y., Hart, Y., Cavey, A., Wroe, S., Blank, M., Shoenfeld, Y., Vincent, A., Palace, J., & Lang, B. (2005) · Neurology · doi:10.1212/01.wnl.0000187129.66353.13 · Cited by 231
Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody tests
Kavanaugh, A. F., Solomon, D. H., & The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines (2002) · Arthritis Care & Research · doi:10.1002/art.10558 · Cited by 225
Patel, D. R., & Richardson, B. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00132-7 · Cited by 158
Hayashi, N., Koshiba, M., Nishimura, K., Sugiyama, D., Nakamura, T., Morinobu, S., Kawano, S., & Kumagai, S. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0028-1 · Cited by 166
The Janus Head of T Cell Aging – Autoimmunity and Immunodeficiency
Goronzy, J. J., Li, G., Yang, Z., & Weyand, C. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00131 · Cited by 134
“REVIEW ARTICLE published: 04 June 2013 doi: 10.3389/fimmu.2013.00131 The Janus head of T cell aging – autoimmunity and immunodeficiency”
BackgroundMethodInfluentialLacroix‐Desmazes, S., Mouthon, L., Coutinho, A., & Kazatchkine, M. D. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250929 · Cited by 109
Autoantibody Determination in the Diagnosis of Systemic Lupus Erythematosus
Kurien, B. T., & Scofield, R. H. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01819.x · Cited by 120
Elderly-Onset Systemic Lupus Erythematosus
Lazaro, D. M. (2007) · Drugs & Aging · doi:10.2165/00002512-200724090-00001 · Cited by 87
Systemic lupus erythematosus biomarkers: the challenging quest
Arriens, C., Wren, J. D., Munroe, M. E., & Mohan, C. (2016) · Rheumatology · doi:10.1093/rheumatology/kew407 · Cited by 102
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
Tsai, C., Robinson, P. V., Spencer, C. A., & Bertozzi, C. R. (2016) · ACS Central Science · doi:10.1021/acscentsci.5b00340 · Cited by 76
Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages
J, M. P. J., Govoni, M., Castellino, G., Rizzo, N., Fotinidi, M., & Trotta, F. (2006) · Rheumatology International · doi:10.1007/s00296-006-0284-3 · Cited by 79
Stability of Natural Self-Reactive Antibody Repertoires During Aging
Lacroix‐Desmazes, S., Mouthon, L., Kaveri, S. V., Kazatchkine, M. D., & Weksler, M. E. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020510401233 · Cited by 69
“In the human, the incidence of a number of autoantibodies in the serum, i.e., rheumatoid factor and antinuclear, anti-DNA, antithyroglobulin, and anticardiolipin antibodies, has been reported to increase with aging ( 11-18 ), although the data remain controversial (19, 20).”
BackgroundFrasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616650 · Cited by 58
Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects
Soni, C., & Reizis, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01601 · Cited by 58
SYSTEMIC LUPUS ERYTHEMATOSUS IN THE ELDERLY
Kammer, G. M., & Mishra, N. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70152-6 · Cited by 51
Lupus érythémateux disséminé survenant après 65 ans
Gaujard, S., Broussolle, C., Cathébras, P. J., Dupond, J. L., Massot, C., Ninet, J., Perrot, H., Durand, D. V., & ROUSSET, H. (2003) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(03)00052-3 · Cited by 27
Fan, R., Zhang, Y., Xu, Y., Tong, J., Chen, Z., Gu, M., Fan, W.-K., Chen, Y., Peng, F., & Jiang, Y. (2020) · Brain and Behavior · doi:10.1002/brb3.1865 · Cited by 27
“…cause inflammation and tissue damage through binding to exposed chromatin fragments or directly to intrinsic antigens by cross-reactivity, or deposing in tissue lesions by forming immune complexes of antibodies with DNA or nucleosomes (Fenton et al., 2009; Rekvig, 2015; Seredkina et al., 2013).”
BackgroundAnti-nuclear antibodies and the optic-spinal form of multiple sclerosis
Fukazawa, T., Kikuchi, S., Sasaki, H., Hamada, K., Hamada, T., Miyasaka, K., & Tashiro, K. (1997) · Journal of Neurology · doi:10.1007/s004150050129 · Cited by 19
Richaud‐Patín, Y., Cabiedes, J., Jakez‐Ocampo, J., Vidaller, A., & Llorente, L. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00243-7 · Cited by 23
Study of procainamide hapten-specific antibodies in rabbits and humans
Adams, L. E., Roberts, S. M., Donovan‐Brand, R., Zimmer, H., & Hess, E. V. (1993) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(93)90006-k · Cited by 16
Llorente, L., Richaud‐Patín, Y., Alvarado, C., Vidaller, A., & Jakez‐Ocampo, J. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-409.x · Cited by 15
Autoantibody Profiling in Lupus Patients using Synthetic Nucleic Acids
Klečka, M., Thybo, C., Macaubas, C., Solov’yov, I. A., Simard, J. F., Balboni, I., Fox, E. J., Voss, A., Mellins, E., & Astakhova, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-23910-5 · Cited by 15
Berens, H. M., Polinski, K. J., Mikuls, T. R., Khatter, S., August, J., Visser, A., Mähler, M., Weisman, M. H., O’Dell, J. R., Keating, R. M., et al. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.180897 · Cited by 11
Phenotypic and functional features of B cells from two different human subcutaneous adipose depots
Frasca, D., Garcia, D., Diaz, A., Romero, M., Thaller, S. R., & Blomberg, B. B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285025 · Cited by 8
“The finding that these autoimmune specificities are also increased in the plasma of healthy elderly individuals [20, 60] has suggested that obesity indeed accelerates age-associated B cell defects.”
BackgroundDrug-Induced Lupus Erythematosus
Richardson, B. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00031-1 · Cited by 8
Damaged DNA marching out of aging nucleus
Hacohen, N., & Lan, Y. Y. (2019) · Aging · doi:10.18632/aging.102340 · Cited by 6
EVALUATION OF ANTI-DS DNA ANTIBODIES IN ANTI-NUCLEAR ANTIBODY POSITIVE OMANI PATIENTS
Alnaqdy, A., Al-Busaidy, J., & Hassan, B. (2007) · Pakistan Journal of Medical Sciences · Cited by 4
AUTOANTIBODIES, AUTOIMMUNE DISEASES, AND VASCULITIS IN THE AGED
Richmond, G. W., & Yu, B.-H. (1993) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(22)00420-9 · Cited by 5
Acute Renal Failure Secondary to Tuberculosis: A Diagnostic Challenge
Khilji, S., Kok, H. K., Wong, L., Dorman, A. M., & Walshe, J. J. (2012) · Case Reports in Nephrology · doi:10.1155/2012/510179 · Cited by 4
“The mechanism of this finding remains unclear [7].”
BackgroundBeck, S. T., da Silva, J. C. N., Schimit, S., Fleck, J. M. C., & dos Santos, R. S. (2009) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442009000400004 · Cited by 3
Önen, F. (1998) · DergiPark (Istanbul University) · Cited by 3
Patel, D. R., & Richardson, B. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00039-x · Cited by 4
Clinical utilization of the international normalized ratio (INR)
Riley, R. S., Rowe, D., & Fisher, L. M. (2000) · Journal of Clinical Laboratory Analysis · doi:10.1002/(sici)1098-2825(2000)14:3<125::aid-jcla7>3.0.co;2-s · Cited by 54
Self-citationFöttinger, F., Krajnc, N., Riedl, K., Leutmezer, F., Ponleitner, M., Rommer, P. S., Kornek, B., Macher, S., Schmied, C., Zebenholzer, K., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16558 · Cited by 5
“In these patient populations, ENA and dsDNA demonstrate very limited PPV and sensitivity [ 25, 26 ].”
Frecuencia de anticuerpos antinucleares en ancianos sanos
Medina, C. O., Hernandez, F. G., Palma, M. D. C., Wichmann, I., RESPALDIZA, N., & Román, J. S. (2004) · Revista española de reumatología: Órgano Oficial de la Sociedad Española de Reumatología · Cited by 2
Systemic lupus in the elderly a rare case in a 72 year-old man
Zulfiqar, A., Duval, Y., Mahmoudi, R., Dramé, M., & Novella, J. (2013) · European Geriatric Medicine · doi:10.1016/j.eurger.2013.02.004
Immunité, auto-immunité et vieillissement
Mouthon, L. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2008.10.007
Current Insights Into Systemic Lupus Erythematosus
Ceccarelli, F., Perricone, C., Valesini, G., & Conti, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00043-8
Metadata
- Authors
- Ruffatti, A., Calligaro, A., Del Ross, T., Bertoli, M. T., Doria, A., Rossi, L., & Todesco, S. V.
- Affiliations
- University of Padua (IT)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- Venue
- Journal of Clinical Immunology
- Published
- 1990-11
- Volume
- 10
- Issue
- 6
- Pages
- 300-303
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W1997089878
- Cited by
- 41
- References
- 27
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 2 · 2020: 1 · 2019: 5 · 2018: 1 · 2016: 2 · 2015: 1 · 2013: 2 · 2012: 2
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- anti-dsDNA antibodies, healthy older adults, prevalence, systemic lupus erythematosus, IgA antibodies, complement fixation, Farr assay, autoantibodies
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Antibodies, Antinuclear, Complement Fixation Tests, DNA, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, Male, Radioimmunoassay, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.